Polyacrylate resin microcapsules for taste masking of antibiotics.
Various microencapsulated dosage forms were prepared to limit the release of an antibiotic in solution for up to 3 days and in the oral cavity following per oral administration. An experimental antibiotic, clarithromycin (TE-031), was used in these studies. The drug was first encapsulated in gelatin followed in some cases by crosslinking with glutaraldehyde. The gelatin microcapsules were then coated with acrylic resins (Eudragit), whose solubility properties vary according to pH. A non-solvent coacervation technique was used to apply the Eudragit resins. It was found that crosslinking the gelatin retarded release of TE-031 somewhat relative to that from uncrosslinked gelatin microcapsules in a 72h release experiment conducted at room temperature. Coating the gelatin microcapsules with Eudragit resins L100, S100, or E100 slowed the release of TE-031 further still; less TE-031 was released over 72 h from the Eudragit-coated formulations prepared with crosslinked gelatin compared with formulations prepared with uncrosslinked gelatin. The Eudragit E100-coated crosslinked gelatin microcapsule formulation was most effective in preventing release of the TE-031 under simulated conditions of storage in an aqueous solution.
Friend
D R
DR
Controlled Release and Biomedical Polymers Department, SRI International, Menlo Park, CA 94025.
D000180:Acrylic Resins / Q000008:administration & dosage*; D002214:Capsules; D017291:Clarithromycin / Q000008:administration & dosage*; D003692:Delayed-Action Preparations; D011109:Polymethacrylic Acids; D012995:Solubility; D013649:Taste
D000180:Acrylic Resins; D002214:Capsules; D003692:Delayed-Action Preparations; D011109:Polymethacrylic Acids; C038300:methylmethacrylate-methacrylic acid copolymer; D017291:Clarithromycin